Cognitive Disorders In Neuroimmunological Diseases

This book offers a detailed review of the remarkable advances that have been made in research on the pathogenesis of a number of neuroimmunological diseases, as well as outlining novel treatments including the use of monoclonal antibodies. Written by renowned experts who have made major contributions in the field, such as identifying neuromyelitis optica as an immunopathological clinical condition, identifying the role of ganglioside and ganglioside-complex antibodies in Guillain-Barré syndrome, and developing a novel treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome, the book summarizes recent advances in basic and clinical research. Neuroimmunological Diseases is a useful resource for not only researchers but also neurologists who are engaged in the management of neuroimmunological diseases.

This fully updated second edition summarises neuropsychological deficits in a broad range of neurological and general medical disorders.

Many clinicians within neurology remain unaware of the significant advances that have taken place in the field of cognitive neuroscience in the last decades, and how these might affect clinical practice. This book provides an introduction to the cognitive and behavioral aspects of the clinical practice of neurology.

This new book presents important recent research on cognitive disorders which are disturbances in the mental process related to thinking, reasoning, and judgement. They include delirium, dementia, and other cognitive disorders. Cognition includes the domains of attention, memory, language, gnosis, visuospatial function, praxis, and executive function, and is traditionally distinguished from the emotions or 'feelings'. Cognitive disorders may disturb one domain specifically, as in a selective impairment of memory (amnesia) or language (aphasia), or, more often, a combination of deficits, as in mental retardation and dementia.

This book contains selected peer-reviewed chapters that cover novel information on cognitive disorders and updated information on dementias written by international researchers. In this project, we discuss the effect of metabolic disorders on the development of cognitive disorders in patients with type 1 diabetes mellitus. In another chapter, the authors highlight the usability of an assistive software application developed for patients with dementia. On the other hand, an extensive review of novel information on different types of dementia is made. This chapter covers the novel aspect of dementia without ignoring its foundation. Therefore, apart from classic issues that cannot be missed in any textbook about cognitive disorders, we introduce updated information on the commonest dementias. The current situation of the prisoner population with dementia in a correctional setting is analyzed in another chapter, and specific recommendations to improve the health outcomes for prisoners are delivered. In more than one chapter, our authors wrote about a copious microtubule-associated protein (tau) as a biological fluid biomarker and tauopathies leading to cognitive disorder and cancer. Finally, the role of the hypothalamus in Alzheimer's disease is discussed. We look forward with confidence and pride to the remarkable role that this book will play for a new vision and mission.

This book describes the latest advances in our psychological understanding of Alzheimer's disease, bringing together the main experts in this field to describe recent developments. It will be valuable for people working in related disciplines, such as neurology, psychiatry and neuroscience researchers, as well as providing an introduction to the field for psychologists.